Q: Hi, I have a 1/3 position in Allergan (AGN), down about 40%. Michael Waterhouse, a Morningstar analyst, makes a strong case that Allergan is considerably undervalued. I’m thinking of adding to my position and would appreciate your opinion. I also hold full positons in GILD, CSH.UN and GUD, as part of a well-diversified portfolio.
Thanks, Kevin
Thanks, Kevin